Toth Financial Advisory Corp increased its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 6.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,183 shares of the company's stock after acquiring an additional 1,104 shares during the period. McKesson makes up about 1.4% of Toth Financial Advisory Corp's investment portfolio, making the stock its 16th largest position. Toth Financial Advisory Corp's holdings in McKesson were worth $11,564,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. GAMMA Investing LLC raised its holdings in shares of McKesson by 75,632.7% in the 1st quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company's stock worth $1,610,567,000 after purchasing an additional 2,389,992 shares in the last quarter. Norges Bank acquired a new position in McKesson in the fourth quarter worth approximately $1,200,361,000. Farallon Capital Management LLC bought a new position in shares of McKesson in the fourth quarter valued at $348,044,000. Marshall Wace LLP lifted its position in shares of McKesson by 59,720.3% during the 4th quarter. Marshall Wace LLP now owns 358,922 shares of the company's stock valued at $204,553,000 after acquiring an additional 358,322 shares during the last quarter. Finally, Leigh Baldwin & CO. LLC bought a new stake in shares of McKesson during the 4th quarter worth $182,861,000. 85.07% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
MCK has been the topic of a number of recent analyst reports. Morgan Stanley boosted their target price on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Mizuho boosted their price objective on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Wall Street Zen raised shares of McKesson from a "buy" rating to a "strong-buy" rating in a research note on Friday, May 30th. UBS Group raised their target price on shares of McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Finally, Bank of America boosted their price target on shares of McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, McKesson has an average rating of "Moderate Buy" and a consensus price target of $692.46.
Read Our Latest Stock Analysis on MCK
McKesson Price Performance
NYSE MCK opened at $712.99 on Monday. The firm has a market capitalization of $89.20 billion, a price-to-earnings ratio of 32.65, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. The company has a 50 day simple moving average of $699.69 and a 200-day simple moving average of $641.34. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $731.00.
McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. The firm had revenue of $90.82 billion for the quarter, compared to analyst estimates of $94 billion. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The company's revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.18 EPS. On average, analysts predict that McKesson Co. will post 32.77 EPS for the current year.
McKesson Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be issued a dividend of $0.71 per share. The ex-dividend date is Monday, June 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.40%. McKesson's dividend payout ratio is 10.99%.
Insider Activity at McKesson
In other news, CFO Britt J. Vitalone sold 6,336 shares of the firm's stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the completion of the sale, the chief financial officer now directly owns 14,760 shares of the company's stock, valued at $10,587,348. This trade represents a 30.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 2,891 shares of the business's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $712.18, for a total value of $2,058,912.38. Following the completion of the sale, the executive vice president now directly owns 2,544 shares of the company's stock, valued at approximately $1,811,785.92. The trade was a 53.19% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,747 shares of company stock valued at $9,852,587. Insiders own 0.11% of the company's stock.
McKesson Company Profile
(
Free Report)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report